A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension

In a crossover design, control of blood pressure by extended release felodipine was compared with control by prolonged action nifedipine in 21 children with renal hypertension. Compliance with once daily felodipine was higher than with nifedipine, at 95.6 (SEM 2.7)% v 78.9 (6.0)% (p = 0.02). Mean di...

Full description

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood 1995-08, Vol.73 (2), p.154-156
Main Authors: Moncica, I, Oh, P I, ul Qamar, I, Scolnik, D, Arbus, G S, Hebert, D, Balfe, J W, Koren, G
Format: Article
Language:English
Subjects:
Adolescent
Antihypertensive agents
Antihypertensive Agents - therapeutic use
Biological and medical sciences
Blood pressure
Cardiovascular system
Child
Cross-Over Studies
Delayed-Action Preparations
Drug Administration Schedule
Felodipine
Felodipine - therapeutic use
Humans
Hypertension
Hypertension, Renal - drug therapy
Medical sciences
Nifedipine
Nifedipine - therapeutic use
Patient Compliance
Pediatrics
Pharmacology. Drug treatments
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b506t-8da33e743b82c191ccf07566f74a1714aa7add39bc882215de71bae71a41a64f3
cites cdi_FETCH-LOGICAL-b506t-8da33e743b82c191ccf07566f74a1714aa7add39bc882215de71bae71a41a64f3
container_end_page 156
container_issue 2
container_start_page 154
container_title Archives of disease in childhood
container_volume 73
creator Moncica, I
Oh, P I
ul Qamar, I
Scolnik, D
Arbus, G S
Hebert, D
Balfe, J W
Koren, G
description In a crossover design, control of blood pressure by extended release felodipine was compared with control by prolonged action nifedipine in 21 children with renal hypertension. Compliance with once daily felodipine was higher than with nifedipine, at 95.6 (SEM 2.7)% v 78.9 (6.0)% (p = 0.02). Mean diastolic blood pressure was lower during the day with felodipine than with nifedipine, at 77.6 (2.4) v 84.4 (2.8) mm Hg (p = 0.05). Similarly, blood pressure load (the percentage of the day during which the child had blood pressure exceeding the upper limits of normal for age) was lower for felodipine than for nifedipine: 43.5 (5.5)% v 61.3 (6.3)%. There was an opposite trend during the night, though this did not reach statistical significance. These data suggest that once a day felodipine is effective in children with hypertension. This may be because of improved compliance.
doi_str_mv 10.1136/adc.73.2.154
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1511218</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77538029</sourcerecordid><originalsourceid>FETCH-LOGICAL-b506t-8da33e743b82c191ccf07566f74a1714aa7add39bc882215de71bae71a41a64f3</originalsourceid><addsrcrecordid>eNp90Utv1DAUBeAIgcpQ2LFFigSCDRn8SuxskKqoUKQKFjyE2Fg3zk3HQ2KndqaPf4_LRCNgwcZenC9H17lZ9pSSNaW8egOdWUu-ZmtainvZiopKFYwIcT9bEUJ4USulHmaPYtwSQplS_Cg7kqUUqqKrrD_JTfAx-isMufHjBMFG73Lf53gzo-uwywMOCBHzHgff2ck6zK_tvMmn4AfvLpIAM9v0kbM9LsC6fHM7YUgVMUWPswc9DBGfLPdx9vXd6ZfmrDj_9P5Dc3JetCWp5kJ1wDlKwVvFDK2pMT2RZVX1UgCVVABI6Dpet0YpxmjZoaQtpAMEhUr0_Dh7u--ddu2InUE3Bxj0FOwI4VZ7sPrvxNmNvvBXmpaUMqpSwculIPjLHcZZjzYaHAZw6HdRS1lyRVid4PN_4NbvgkuP05zIWlU1k3d1r_fq908O2B9GoUTfbU-n7WnJNUsTiMSf_Tn-AS_rSvmLJYdoYOgDOGPjgfGKJckTK_bMxhlvDjGEn7qSXJb647dGf2_UZ3X2o9Fl8q_2vh23_x_wF0PtwHg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3079869278</pqid></control><display><type>article</type><title>A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension</title><source>Education Collection (Proquest) (PQ_SDU_P3)</source><source>Social Science Premium Collection (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Moncica, I ; Oh, P I ; ul Qamar, I ; Scolnik, D ; Arbus, G S ; Hebert, D ; Balfe, J W ; Koren, G</creator><creatorcontrib>Moncica, I ; Oh, P I ; ul Qamar, I ; Scolnik, D ; Arbus, G S ; Hebert, D ; Balfe, J W ; Koren, G</creatorcontrib><description>In a crossover design, control of blood pressure by extended release felodipine was compared with control by prolonged action nifedipine in 21 children with renal hypertension. Compliance with once daily felodipine was higher than with nifedipine, at 95.6 (SEM 2.7)% v 78.9 (6.0)% (p = 0.02). Mean diastolic blood pressure was lower during the day with felodipine than with nifedipine, at 77.6 (2.4) v 84.4 (2.8) mm Hg (p = 0.05). Similarly, blood pressure load (the percentage of the day during which the child had blood pressure exceeding the upper limits of normal for age) was lower for felodipine than for nifedipine: 43.5 (5.5)% v 61.3 (6.3)%. There was an opposite trend during the night, though this did not reach statistical significance. These data suggest that once a day felodipine is effective in children with hypertension. This may be because of improved compliance.</description><identifier>ISSN: 0003-9888</identifier><identifier>EISSN: 1468-2044</identifier><identifier>DOI: 10.1136/adc.73.2.154</identifier><identifier>PMID: 7574861</identifier><identifier>CODEN: ADCHAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</publisher><subject>Adolescent ; Antihypertensive agents ; Antihypertensive Agents - therapeutic use ; Biological and medical sciences ; Blood pressure ; Cardiovascular system ; Child ; Cross-Over Studies ; Delayed-Action Preparations ; Drug Administration Schedule ; Felodipine ; Felodipine - therapeutic use ; Humans ; Hypertension ; Hypertension, Renal - drug therapy ; Medical sciences ; Nifedipine ; Nifedipine - therapeutic use ; Patient Compliance ; Pediatrics ; Pharmacology. Drug treatments</subject><ispartof>Archives of disease in childhood, 1995-08, Vol.73 (2), p.154-156</ispartof><rights>1995 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD Aug 1995</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b506t-8da33e743b82c191ccf07566f74a1714aa7add39bc882215de71bae71a41a64f3</citedby><cites>FETCH-LOGICAL-b506t-8da33e743b82c191ccf07566f74a1714aa7add39bc882215de71bae71a41a64f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3079869278/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3079869278?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,21378,21394,27924,27925,33611,33612,33877,33878,43733,43880,53791,53793,74221,74397</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3627573$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7574861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moncica, I</creatorcontrib><creatorcontrib>Oh, P I</creatorcontrib><creatorcontrib>ul Qamar, I</creatorcontrib><creatorcontrib>Scolnik, D</creatorcontrib><creatorcontrib>Arbus, G S</creatorcontrib><creatorcontrib>Hebert, D</creatorcontrib><creatorcontrib>Balfe, J W</creatorcontrib><creatorcontrib>Koren, G</creatorcontrib><title>A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension</title><title>Archives of disease in childhood</title><addtitle>Arch Dis Child</addtitle><description>In a crossover design, control of blood pressure by extended release felodipine was compared with control by prolonged action nifedipine in 21 children with renal hypertension. Compliance with once daily felodipine was higher than with nifedipine, at 95.6 (SEM 2.7)% v 78.9 (6.0)% (p = 0.02). Mean diastolic blood pressure was lower during the day with felodipine than with nifedipine, at 77.6 (2.4) v 84.4 (2.8) mm Hg (p = 0.05). Similarly, blood pressure load (the percentage of the day during which the child had blood pressure exceeding the upper limits of normal for age) was lower for felodipine than for nifedipine: 43.5 (5.5)% v 61.3 (6.3)%. There was an opposite trend during the night, though this did not reach statistical significance. These data suggest that once a day felodipine is effective in children with hypertension. This may be because of improved compliance.</description><subject>Adolescent</subject><subject>Antihypertensive agents</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blood pressure</subject><subject>Cardiovascular system</subject><subject>Child</subject><subject>Cross-Over Studies</subject><subject>Delayed-Action Preparations</subject><subject>Drug Administration Schedule</subject><subject>Felodipine</subject><subject>Felodipine - therapeutic use</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension, Renal - drug therapy</subject><subject>Medical sciences</subject><subject>Nifedipine</subject><subject>Nifedipine - therapeutic use</subject><subject>Patient Compliance</subject><subject>Pediatrics</subject><subject>Pharmacology. Drug treatments</subject><issn>0003-9888</issn><issn>1468-2044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>ALSLI</sourceid><sourceid>CJNVE</sourceid><sourceid>M0P</sourceid><recordid>eNp90Utv1DAUBeAIgcpQ2LFFigSCDRn8SuxskKqoUKQKFjyE2Fg3zk3HQ2KndqaPf4_LRCNgwcZenC9H17lZ9pSSNaW8egOdWUu-ZmtainvZiopKFYwIcT9bEUJ4USulHmaPYtwSQplS_Cg7kqUUqqKrrD_JTfAx-isMufHjBMFG73Lf53gzo-uwywMOCBHzHgff2ck6zK_tvMmn4AfvLpIAM9v0kbM9LsC6fHM7YUgVMUWPswc9DBGfLPdx9vXd6ZfmrDj_9P5Dc3JetCWp5kJ1wDlKwVvFDK2pMT2RZVX1UgCVVABI6Dpet0YpxmjZoaQtpAMEhUr0_Dh7u--ddu2InUE3Bxj0FOwI4VZ7sPrvxNmNvvBXmpaUMqpSwculIPjLHcZZjzYaHAZw6HdRS1lyRVid4PN_4NbvgkuP05zIWlU1k3d1r_fq908O2B9GoUTfbU-n7WnJNUsTiMSf_Tn-AS_rSvmLJYdoYOgDOGPjgfGKJckTK_bMxhlvDjGEn7qSXJb647dGf2_UZ3X2o9Fl8q_2vh23_x_wF0PtwHg</recordid><startdate>19950801</startdate><enddate>19950801</enddate><creator>Moncica, I</creator><creator>Oh, P I</creator><creator>ul Qamar, I</creator><creator>Scolnik, D</creator><creator>Arbus, G S</creator><creator>Hebert, D</creator><creator>Balfe, J W</creator><creator>Koren, G</creator><general>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88B</scope><scope>88E</scope><scope>88I</scope><scope>8A4</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>CJNVE</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0P</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEDU</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19950801</creationdate><title>A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension</title><author>Moncica, I ; Oh, P I ; ul Qamar, I ; Scolnik, D ; Arbus, G S ; Hebert, D ; Balfe, J W ; Koren, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b506t-8da33e743b82c191ccf07566f74a1714aa7add39bc882215de71bae71a41a64f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adolescent</topic><topic>Antihypertensive agents</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blood pressure</topic><topic>Cardiovascular system</topic><topic>Child</topic><topic>Cross-Over Studies</topic><topic>Delayed-Action Preparations</topic><topic>Drug Administration Schedule</topic><topic>Felodipine</topic><topic>Felodipine - therapeutic use</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension, Renal - drug therapy</topic><topic>Medical sciences</topic><topic>Nifedipine</topic><topic>Nifedipine - therapeutic use</topic><topic>Patient Compliance</topic><topic>Pediatrics</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moncica, I</creatorcontrib><creatorcontrib>Oh, P I</creatorcontrib><creatorcontrib>ul Qamar, I</creatorcontrib><creatorcontrib>Scolnik, D</creatorcontrib><creatorcontrib>Arbus, G S</creatorcontrib><creatorcontrib>Hebert, D</creatorcontrib><creatorcontrib>Balfe, J W</creatorcontrib><creatorcontrib>Koren, G</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection【Remote access available】</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Education Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Education Periodicals</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Education Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Education Database</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Education</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Archives of disease in childhood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moncica, I</au><au>Oh, P I</au><au>ul Qamar, I</au><au>Scolnik, D</au><au>Arbus, G S</au><au>Hebert, D</au><au>Balfe, J W</au><au>Koren, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension</atitle><jtitle>Archives of disease in childhood</jtitle><addtitle>Arch Dis Child</addtitle><date>1995-08-01</date><risdate>1995</risdate><volume>73</volume><issue>2</issue><spage>154</spage><epage>156</epage><pages>154-156</pages><issn>0003-9888</issn><eissn>1468-2044</eissn><coden>ADCHAK</coden><abstract>In a crossover design, control of blood pressure by extended release felodipine was compared with control by prolonged action nifedipine in 21 children with renal hypertension. Compliance with once daily felodipine was higher than with nifedipine, at 95.6 (SEM 2.7)% v 78.9 (6.0)% (p = 0.02). Mean diastolic blood pressure was lower during the day with felodipine than with nifedipine, at 77.6 (2.4) v 84.4 (2.8) mm Hg (p = 0.05). Similarly, blood pressure load (the percentage of the day during which the child had blood pressure exceeding the upper limits of normal for age) was lower for felodipine than for nifedipine: 43.5 (5.5)% v 61.3 (6.3)%. There was an opposite trend during the night, though this did not reach statistical significance. These data suggest that once a day felodipine is effective in children with hypertension. This may be because of improved compliance.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</pub><pmid>7574861</pmid><doi>10.1136/adc.73.2.154</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-9888
ispartof Archives of disease in childhood, 1995-08, Vol.73 (2), p.154-156
issn 0003-9888
1468-2044
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1511218
source Education Collection (Proquest) (PQ_SDU_P3); Social Science Premium Collection (Proquest) (PQ_SDU_P3); PubMed Central
subjects Adolescent
Antihypertensive agents
Antihypertensive Agents - therapeutic use
Biological and medical sciences
Blood pressure
Cardiovascular system
Child
Cross-Over Studies
Delayed-Action Preparations
Drug Administration Schedule
Felodipine
Felodipine - therapeutic use
Humans
Hypertension
Hypertension, Renal - drug therapy
Medical sciences
Nifedipine
Nifedipine - therapeutic use
Patient Compliance
Pediatrics
Pharmacology. Drug treatments
title A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T16%3A02%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20crossover%20comparison%20of%20extended%20release%20felodipine%20with%20prolonged%20action%20nifedipine%20in%20hypertension&rft.jtitle=Archives%20of%20disease%20in%20childhood&rft.au=Moncica,%20I&rft.date=1995-08-01&rft.volume=73&rft.issue=2&rft.spage=154&rft.epage=156&rft.pages=154-156&rft.issn=0003-9888&rft.eissn=1468-2044&rft.coden=ADCHAK&rft_id=info:doi/10.1136/adc.73.2.154&rft_dat=%3Cproquest_pubme%3E77538029%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b506t-8da33e743b82c191ccf07566f74a1714aa7add39bc882215de71bae71a41a64f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3079869278&rft_id=info:pmid/7574861&rfr_iscdi=true